We are thrilled to be featured as one of the 124 novel devices granted marketing authorization by the CDRH in 2023. To read the full report, check out the link below:
Endolumik made the FDA’s Annual Report!
We are thrilled to be featured as one of the 124 novel devices granted marketing authorization by the CDRH in 2023. To read the full report, check out the link below: